Guy's and St Thomas' NHS Foundation Trust
|Guy's and St Thomas' NHS Foundation Trust|
|Type||NHS Foundation Trust|
|Hospitals||Guy's Hospital |
St Thomas' Hospital
Evelina London Children's Hospital
|Chair||Sir Hugh Taylor|
|Chief executive||Amanda Pritchard|
|Number of employees||16,200|
Guy's and St Thomas' NHS Foundation Trust is an NHS foundation trust of the English National Health Service, one of the prestigious Shelford Group. It runs Guy's Hospital in London Bridge, St Thomas' Hospital in Waterloo, Evelina London Children's Hospital and community services in Lambeth and Southwark.
Guy’s and St Thomas’ was one of the largest hospital trusts in the country when it was founded, with around 16,200 staff; 25,200 Foundation trust members; an annual turnover of almost £1.5 billion; and 2.4 million patient contacts a year.
In December 2013 it was announced that a proposed merger with King's College Hospital and South London and Maudsley NHS Foundation Trust foundation trusts had been suspended because of doubts about the reaction of the Competition Commission.
In 2013 the trust established a subsidiary company, Essentia Trading Ltd, to which 48 estates and facilities staff were transferred. It provides consultancy services on strategy and estate development. The intention was to achieve VAT benefits, as well as pay bill savings, by recruiting new staff on less expensive non-NHS contracts. VAT benefits arise because NHS trusts can only claim VAT back on a small subset of goods and services they buy. The Value Added Tax Act 1994 provides a mechanism through which NHS trusts can qualify for refunds on contracted out services.
It is one of the biggest provider of specialised services in England, which generated an income of £383.7 million in 2014/5.
In October 2018 it had to impose geographical limits on specialist paediatric referrals for dermatology and urology after a large increase in referrals from North London, Kent and Sussex made the waiting times unmanageable.
The trust entered into a contract with Johnson & Johnson in November 2017 for £310 million thought to run for 10 years. It includes a “managed service agreement" for the procurement of prosthetics, surgical instruments and other consumables for orthopaedic surgery and the development of eight new operating theatres on the Guy's hospital site.
The trust expects to finish 2015-16 with a deficit of more than £37 million as a result of changes to the NHS tariff.
It was named by the Health Service Journal as one of the top hundred NHS trusts to work for in 2015. At that time it had 12,198 full-time equivalent staff and a sickness absence rate of 3.35%. 85% of staff recommend it as a place for treatment and 78% recommended it as a place to work.
- "Guy's and St Thomas' NHS Foundation Trust". NHS Partners. Retrieved 15 December 2013.
- "Trust super-merger shelved". Health Service Journal. 5 December 2013. Retrieved 5 December 2013.
- "In full: Trusts with staff transfer plans". Health Service Journal. 14 February 2017. Retrieved 15 February 2018.
- "NHS DNA scheme to fight cancer and genetic diseases". BBC News. 22 December 2014. Retrieved 22 December 2014.
- "Viapath - a New Brand, Same Commitment to Transform Pathology Services". Select Science. 9 May 2014. Retrieved 28 May 2014.
- "Analysed: The biggest NHS providers of specialised services". Health Service Journal. 16 October 2015. Retrieved 16 November 2015.
- "Major tertiary provider restricts out-of-area referrals". Health Service Journal. 31 October 2018. Retrieved 3 December 2018.
- "NHS expands private care to help fill £20bn funding gap". Financial Times. 2 March 2016. Retrieved 26 January 2017.
- "Trust awards £300m orthopaedics contract to US firm". Health Service Journal. 17 November 2017. Retrieved 28 December 2017.
- "Rollover tariff trusts expect massive deficits". Health Service Journal. 26 May 2015. Retrieved 20 June 2015.
- "HSJ reveals the best places to work in 2015". Health Service Journal. 7 July 2015. Retrieved 23 September 2015.